updated Thu. June 13, 2024
-
usstockjournal
February 19, 2018
Abbott Laboratories (ABT) addition 1.13% with the finishing price of $60.17 in Friday Trading Session. With Latest addition move, stock price showed -6.86% down in value from one year high price and revealed 42.21% upward in value from its one year low price. In the recent week Abbott LaboratoriesÃÂ ...
Danvers Record
February 19, 2018
Research analysts are predicting that Abbott Laboratories (NYSE:ABT) will report earnings of $0.58 per share when the firm issues their next quarterly report. This is the consensus earnings per share number according to data from Zack's Research. Abbott Laboratories (NYSE:ABT) closed the last sessionÃÂ ...
Alpha Beta Stock
February 19, 2018
Abbott Laboratories (NYSE: ABT) has grabbed attention from the analysts when it experienced a change of 1.13% in the last trading session to close at $60.17. A total of 7,800,306 shares exchanged hands during the intra-day trade contrast with its average trading volume of 6.96M shares, while its relativeÃÂ ...
The Ledger Gazette
February 19, 2018
Abbott Laboratories logo Starfire Investment Advisers Inc. grew its holdings in Abbott Laboratories (NYSE:ABT) by 28.0% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 5,989 shares of the healthcare productÃÂ ...
Market Realist
February 3, 2018
On January 24, 2018, during Abbott Laboratories' (ABT) 4Q17 and fiscal 2017 earnings release, the company announced its fiscal 2018 guidance. Abbott provided a strong fiscal 2018 performance outlook, and the stock registered a rise of ~4.2% on the day of the earnings announcement. On January 24ÃÂ ...
Market Realist
February 2, 2018
Abbott Laboratories (ABT) posted a strong earnings results on January 24, 2018, surpassing Wall Street estimates and posting earnings at the higher end of its guidance. ABT stock registered a rise of more than 4% that day. Abbott Laboratories had an eventful year in 2017, with a number of key strategicÃÂ ...
Market Realist
February 1, 2018
On January 29, 2018, Abbott Laboratories (ABT) closed trading at $63.31 per share. The company reported its 52-week high of $64.60 on January 25, 2018. Before the earnings release, ABT stock was trading near these highs, and then the stock rose to register a 52-week high following the company'sÃÂ ...
The Ledger Gazette
February 1, 2018
Abbott Laboratories logo Abbott Laboratories (NYSE:ABT) issued an update on its FY18 earnings guidance on Wednesday morning. The company provided earnings per share guidance of $2.80-2.90 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.83. AbbottÃÂ ...
The Ledger Gazette
February 1, 2018
Abbott Laboratories logo HL Financial Services LLC reduced its holdings in Abbott Laboratories (NYSE:ABT) by 4.0% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 290,932 shares of the healthcare productÃÂ ...
Nasdaq
January 24, 2018
(RTTNews.com) - Abbott Laboratories ( ABT ) revealed earnings for its fourth quarter that rose compared to the same period last year. The company said its bottom line advanced to $1.30 billion, or $0.74 per share. This was higher than $0.97 billion, or $0.65 per share, in last year's fourth quarter. AnalystsÃÂ ...
CNBC
January 24, 2018
An employee walks near an Abbott Laboratories sign at the company's headquarters complex in Abbott Park. Daniel Acker | Bloomberg | Getty Images. An employee walks near an Abbott Laboratories sign at the company's headquarters complex in Abbott Park, Illinois. Abbott Laboratories' fourth-quarterÃÂ ...
Seeking Alpha
January 8, 2018
Good afternoon, everybody. It's my pleasure to introduce our next speaker on behalf of Abbott Labs. We have Brian Yoor, the Company's Executive Vice-President and Chief Financial Officer. Following Brian's remarks, we will have a break-out session in the Board's room across the hall. Brian? Brian Yoor.
Investorplace.com
December 31, 1999
Factors in Abbott Laboratories's (NYSE:ABT) current Buy recommendation is a numerical calculation of risk/reward that is attractive, analytical scoring that is near average, and a ranking in the company's industry group that is in the top quarter, and a ranking in its sector group that is in the top quarter.
Medill Reports: Chicago
December 31, 1999
Shares of Abbott Laboratories (NYSE: ABT), an Illinois-based broad range healthcare company, rose 3 percent after the company reported adjusted earnings that slightly exceeded analysts' expectations in the fourth quarter ended Dec. 31. On a GAAP basis, Abbott reported a net loss of $828 million, or 48ÃÂ ...
Aiken Advocate
December 30, 2017
In taking a look at some other notable technicals, Abbott Laboratories (NYSE:ABT)'s ROIC is 0.168704. The ROIC 5 year average is 0.115403 and the ROIC Quality ratio is 5.563729. ROIC is a profitability ratio that measures the return that an investment generates for those providing capital. ROIC helpsÃÂ ...
Frisco Fastball
December 30, 2017
Investors sentiment decreased to 0.87 in 2017 Q3. Its down 0.01, from 0.88 in 2017Q2. It fall, as 47 investors sold Abbott Laboratories shares while 563 reduced holdings. 111 funds opened positions while 421 raised stakes. 1.21 billion shares or 0.79% less from 1.22 billion shares in 2017Q2 were reportedÃÂ ...
BZ Weekly
December 29, 2017
Investors sentiment decreased to 0.87 in 2017 Q3. Its down 0.01, from 0.88 in 2017Q2. It turned negative, as 47 investors sold Abbott Laboratories shares while 563 reduced holdings. 111 funds opened positions while 421 raised stakes. 1.21 billion shares or 0.79% less from 1.22 billion shares in 2017Q2ÃÂ ...
StockNewsJournal
December 28, 2017
Abbott Laboratories (ABT) is an interesting player in the Healthcare space, with a focus on Medical Appliances & Equipment. The stock has been active on the tape, currently trading at $57.47, up from yesterday's close by 0.82%. Given the stock's recent action, it seemed like a good time to take a closer lookÃÂ ...
Seeking Alpha
December 19, 2017
Year-End Portfolio Pruning, Part 2: Abbott Labs: Buy The Rumor, Sell The News. Dec.19.17 | About: Abbott Laboratories (ABT) ÷ Hale Stewart. Bonds, commodities, ETF investing, long/short equity. The Law Office of Hale Stewart. Get email alertsà...
Investorplace.com
December 12, 2017
The current recommendation of Buy for Abbott Laboratories (NYSE:ABT) has been derived by using Louis Navellier's investing methods and his Portfolio Grader stock evaluator. This represents no change from the previous week and is the same ranking ABT has had from Portfolio Grader for 3 months.
Benzinga
December 12, 2017
Abbott Laboratories Makes BMO Capital's Top Picks List. Jayson Derrick , Benzinga Staff Writer {{following ? "Following" : "Follow"}}. December 12, 2017 12:34pm Comments. Share: Abbott Laboratories Makes BMO Capital's Top Picks List. Related ABT ÷ 5 Biggest Price Target Changes For Tuesday ÷ Benzinga's Topà...
Nasdaq
December 9, 2017
Abbott Laboratories is a health care company that manufactures medical devices, blood glucose monitoring kits, nutritional healthcare products, diagnostic products and equipment, and branded generic drugs. Abbott Laboratories has a market cap of $95.11 billion; its shares were traded at around $54.64ÃÂ ...
The News Journal
December 3, 2017
With the amassed value of the company based on its existing stock price alongside the total amount of outstanding stocks, today's market cap for Abbott Laboratories is valued at 96.17B. The value of the Market cap relatively ensures a stable and secure position for the company, and can be easily ...
StockNewsJournal
December 2, 2017
Abbott Laboratories (NYSE:ABT), maintained return on investment for the last twelve months at 4.16, higher than what Reuters data shows regarding industry's average. The average of this ratio is 15.17 for the industry and sector's best figure appears 14.53. Abbott Laboratories (NYSE:ABT), at its latest ...
StockNewsJournal
November 30, 2017
Abbott Laboratories (NYSE:ABT) market capitalization at present is $96.94B at the rate of $56.02 a share. The firm's price-to-sales ratio was noted 3.89 in contrast with an overall industry average of 3.94. Most of the active traders and investors are keen to find ways to compare the value of stocks.
Market Realist
November 22, 2017
During its 3Q17 earnings release on October 18, 2017, Abbott Laboratories (ABT) provided an updated guidance for fiscal 2017 and 4Q17. Abbott raised its fiscal 2017 guidance, and ABT stock gained ~1.3% that same day. The Vanguard Dividend Appreciation ETF (VIG) also registered a rise in its price.
Investorplace.com
November 20, 2017
After experiencing some profit-taking in the aftermath of the company's most recent earnings announcement on Oct. 18, Abbott Laboratories (NYSE:ABT) has stabilized and completed a bullish “wedge” continuation pattern on Thursday by breaking above the down-trending resistance level that started in ...
StockNewsTimes
November 19, 2017
Galena Biopharma (NASDAQ: GALE) and Abbott Laboratories (NYSE:ABT) are both pharmaceuticals – nec companies, but which is the ...
The Ledger Gazette
November 19, 2017
Abbott Laboratories logo Zacks Investment Research upgraded shares of Abbott Laboratories (NYSE:ABT) from a hold rating to a buy rating in ...
The News Journal
November 17, 2017
The top gainer with a security that increased in price during today's trading was Abbott Laboratories (NYSE:ABT). Abbott Laboratories had a ...
The Ledger Gazette
November 13, 2017
Abbott Laboratories logo Zacks Investment Research upgraded shares of Abbott Laboratories (NYSE:ABT) from a hold rating to a buy rating in ...
The Ledger Gazette
November 12, 2017
Abbott Laboratories logo Abbott Laboratories (NYSE:ABT) EVP Daniel Gesua Sive Salvadori sold 96,603 shares of the company's stock in a ...
Seeking Alpha
November 3, 2017
The findings of a new study just published in the Lancet counter decades of clinical experience on the use of stents to treat chest pain.
TopChronicle
November 3, 2017
Abbott Laboratories (NYSE:ABT) closed its last session at $54. The stock traded within a range of $53.61 and $54.57. The company operates in ...
StockNewsJournal
November 3, 2017
Abbott Laboratories (NYSE:ABT) plunged -0.42% with the closing price of $54.00. The overall volume in the last trading session was 7.64Â ...
KSTP.com
November 3, 2017
Eight employees of Abbott Laboratories in Little Canada have some happy hours coming their way. A group of colleagues in the medical device ...
StockNewsJournal
November 2, 2017
Abbott Laboratories (ABT) is an interesting player in the Healthcare space, with a focus on Medical Appliances & Equipment. The stock has ...
Investorplace.com
November 1, 2017
The current recommendation of Buy for Abbott Laboratories (NYSE:ABT) is computed using the system for investing of Louis Navellier and his ...
Nasdaq
October 28, 2017
At Holdings Channel , we have reviewed the latest batch of the 21 most recent 13F filings for the 09/30/2017 reporting period, and noticed that ...
Seeking Alpha
October 28, 2017
2017 saw closing of both and substantial integration of St. Jude, with the smaller Alere integration just beginning. 2018 shows great potential as ...
Seeking Alpha
October 20, 2017
I love earnings season. For a few weeks every three months, investors are given a look inside of a company's fundamentals to get a chance to ...
Market Realist
October 20, 2017
Headquartered in Illinois, Abbott Laboratories (ABT) is one of the leading healthcare companies. It has operations in more than 150 countries ...
Motley Fool
October 19, 2017
Good morning, and thank you for standing by. Welcome to Abbott's third quarter 2017 earnings conference call. All participants will be able to ...
Seeking Alpha
October 19, 2017
Abbott Laboratories (ABT) is a true long-term outperformer. The reason for that is multifold, yet simple. Abbott is great at allocating capital, runs ...
Proactive Investors UK
October 19, 2017
Wall Street expects Abbott Laboratories (NYSE:ABT) to post quarterly earnings at US$0.65 a share on revenue of US$6.71bn before the ...
Alpha Beta Stock
October 19, 2017
Abbott Laboratories (NYSE: ABT) has grabbed attention from the analysts when it experienced a change of 1.63% in the current trading session ...
Seeking Alpha
October 19, 2017
Good morning and thank you for standing by. Welcome to Abbott's Third Quarter 2017 Earnings Conference Call. All participants will be able to ...
StreetInsider.com
October 18, 2017
Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite.
Investorplace.com (blog)
October 18, 2017
Portfolio Grader currently ranks Abbott Laboratories (NYSE:ABT) a Buy. Using Louis Navellier's investing system, this analytical tool assesses ...
Investorplace.com
October 11, 2017
Portfolio Grader currently ranks Abbott Laboratories (NYSE:ABT) a Buy. Using Louis Navellier's investing approach, this analytical tool ...
